
YHO-13351
CAS No. 1346753-00-1
YHO-13351( YHO13351 )
Catalog No. M11408 CAS No. 1346753-00-1
YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 147 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameYHO-13351
-
NoteResearch use only, not for human use.
-
Brief DescriptionYHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
-
DescriptionYHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo; YHO-13351 is rapidly converted into YHO-13177 after its oral or intravenous administration, significantly increases the survival time of mice inoculated with BCRP-transduced murine leukemia P388 cells and suppressed the tumor growth in an HCT116/BCRP xenograft model coadministration of irinotecan.
-
In Vitro——
-
In Vivo——
-
SynonymsYHO13351
-
PathwayMembrane Transporter/Ion Channel
-
TargetBCRP
-
RecptorBCRP
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1346753-00-1
-
Formula Weight579.7286
-
Molecular FormulaC27H37N3O7S2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 38 mg/mL
-
SMILESCCN(CC)CC(=O)OC1CCN(CC1)C2=CC=C(S2)C=C(C#N)C3=CC(=C(C=C3)OC)OC.CS(=O)(=O)O
-
Chemical NameGlycine, N,N-diethyl-, 1-[5-[(1Z)-2-cyano-2-(3,4-dimethoxyphenyl)ethenyl]-2-thienyl]-4-piperidinyl ester, methanesulfonate (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yamazaki R, et al. Mol Cancer Ther. 2011 Jul;10(7):1252-63.
molnova catalog



related products
-
YHO-13177
YHO-13177 is a acrylonitrile derivative and active form of YHO-13351 that can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo.
-
6,8-Diprenylnaringen...
6,8-Diprenylnaringenin is a natural product from hop Humulus lupulus. 6,8-Diprenylnaringenin is a breast cancer resistance protein(BCRP) inhibitor with some estrogenicity.
-
Ko-143
A nontoxic analog of fungal toxin fumitremorgin C and potent, orally bioavailable inhibitor of BCRP (ABCG2) with EC90 of 26 nM.